Esim O, Savaser A, Kurbanoglu S, et al.
Journal of Pharmaceutical and Biomedical Analysis, 2017, 142: 74-83.Eletriptan Hydrobromide is a serotonin 5-HT1 receptor agonist and it used for the treatment of migraine headaches with or without aura. Even if the drug is well absorbed after oral administration, it has some drawbacks like first pass metabolism and decrease in bioavailability after migraine attacks. Encapsulation of drug into polymeric nanoparticles is one of the methods for protecting the drug against degradation. Read More